Faculty profile

Vera Mazurak

ResearcherAgricultural, Food and Nutritional ScienceUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Vera Mazurak

Researcher

Agricultural, Food and Nutritional Science

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
19 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2020.
Supervised 1 trainee who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Essential Fatty Acids Inflammation Clinical Symptoms Immune Cells Lung Function N-3 Fatty Acids Oxylipins N-3 Polyunsaturated Fatty Acids

Latest papers

Tumor and red blood cell fatty acid composition as a potential indicator of outcomes in breast cancer: Findings from a retrospective cohort study.
Prostaglandins, leukotrienes, and essential fatty acids · 2026
Lysosomal salvage of neuronal lipids enables glial infiltration of synaptic regions.
Neuron · 2026
Nutritional strategies against skeletal muscle wasting in cancer-associated cachexia: the role of β-hydroxybutyrate and polyunsaturated fatty acids.
Translational oncology · 2026

All 34 publications

Latest funding

Role of saturated fatty acids (SFAs) play in cancer-related lymphedema progression
CIHR · 2026 · Co-investigator
$837,676
Addressing the distressing: Evaluating enzyme replacement therapy as a strategy to prevent malnutrition and control digestive symptoms for people with inoperable pancreatic cancer
CIHR · 2021 · Supervisor
$105,000
Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID-19 Infection
CIHR · 2020 · Nominated PI
$344,250

All 12 grants and awards

34 publications.

Tumor and red blood cell fatty acid composition as a potential indicator of outcomes in breast cancer: Findings from a retrospective cohort study.

Munhoz J, Goruk S, Mazurak V, Ghosh S, Hemmings DG, Field CJ

Prostaglandins, leukotrienes, and essential fatty acids2026

DOI: 10.1016/j.plefa.2026.102733 PMID: 41844486

Lysosomal salvage of neuronal lipids enables glial infiltration of synaptic regions.

Theisen EK, Rivas-Serna IM, Cheng P, Lee RJ, Thomas CI, Darehshouri A, Jay TR, Kunduri G, Nguyen TT, Mazurak V, Thomas Clandinin M, Clandinin TR, Vaughen JP

Neuron2026

DOI: 10.1016/j.neuron.2026.02.006 PMID: 41887214

Nutritional strategies against skeletal muscle wasting in cancer-associated cachexia: the role of β-hydroxybutyrate and polyunsaturated fatty acids.

Hay B, Brun A, Fougerat A, Mazurak V, Le Bacquer O, Talvas J, Capel F

Translational oncology2026

DOI: 10.1016/j.tranon.2025.102596 PMID: 41218549

The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial.

Munhoz J, Bigras G, Newell M, Rivas-Serna IM, Mazurak V, Goruk S, Joy AA, Ghosh S, Courneya KS, Hemmings DG, Field CJ

The Journal of nutritional biochemistry2025

DOI: 10.1016/j.jnutbio.2025.110025 PMID: 40651709

Molecular subtypes of human skeletal muscle in cancer cachexia.

Bhatt BJ, Ghosh S, Mazurak V, Brun AQ, Bathe O, Baracos VE, Damaraju S

Nature2025

DOI: 10.1038/s41586-025-09502-0 PMID: 40931079

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial.

Munhoz J, Newell M, Bigras G, Goruk S, Joy AA, Ghosh S, Courneya KS, Mazurak V, Douglas CM, Zhu X, Zorniak B, Mackey J, Junco JM, Hiller JP, King K, Basi SK, Field CJ

International journal of cancer2025

DOI: 10.1002/ijc.35517 PMID: 40490846

Early-life feeding of arachidonic acid and docosahexaenoic acid beneficially modulated ileum and splenocyte oxylipins to support oral tolerance development in allergy-prone BALB/c mice.

Wang R, Patel D, Goruk S, Serna MR, Mazurak V, Richard C, Field C

Prostaglandins, leukotrienes, and essential fatty acids2025

DOI: 10.1016/j.plefa.2025.102689 PMID: 40440927

Type II fibre atrophy and nuclear disruption in decompensated cirrhosis.

Motamedrad M, Ebadi M, Sanchez-Fernandez N, Parente A, Dunichand-Hoedl AR, Rider E, Kneteman NM, Shapiro AMJ, Bigam D, Dajani K, Anderson B, Baracos VE, Mazurak V, Montano-Loza AJ

JHEP reports : innovation in hepatology2025

DOI: 10.1016/j.jhepr.2025.101455 PMID: 40810104

Perspective: Implications of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on the Immune System during Cancer Chemotherapy: Perspectives from Current Clinical Evidence.

Munhoz J, Mazurak V, Field CJ

Advances in nutrition (Bethesda, Md.)2025

DOI: 10.1016/j.advnut.2025.100464 PMID: 40523478

Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial.

Munhoz J, Newell M, Goruk S, Ghosh S, Patel D, Joy AA, Bigras G, Mazurak V, Courneya KS, Hemmings DG, Field CJ

Breast cancer research : BCR2025

DOI: 10.1186/s13058-025-02048-z PMID: 40405290

Something wrong or missing on this profile? Suggest a correction

Vera Mazurak

Research

Latest papers

Latest funding

Tumor and red blood cell fatty acid composition as a potential indicator of outcomes in breast cancer: Findings from a retrospective cohort study.

Lysosomal salvage of neuronal lipids enables glial infiltration of synaptic regions.

Nutritional strategies against skeletal muscle wasting in cancer-associated cachexia: the role of &#x3b2;-hydroxybutyrate and polyunsaturated fatty acids.

The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial.

Molecular subtypes of human skeletal muscle in cancer cachexia.

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial.

Early-life feeding of arachidonic acid and docosahexaenoic acid beneficially modulated ileum and splenocyte oxylipins to support oral tolerance development in allergy-prone BALB/c mice.

Type II fibre atrophy and nuclear disruption in decompensated cirrhosis.

Perspective: Implications of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on the Immune System during Cancer Chemotherapy: Perspectives from Current Clinical Evidence.

Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial.

Frequent collaborators

Catherine Field

Geoff Ball

Donna Vine

Puneeta Tandon

Lynne-Marie Postovit

Vickie Baracos

Leah Gramlich

Kerry Courneya

Kristi Baker

Oliver Bathe

Caroline Richard

Lynne-Marie Postovit

Gregg Nelson

Jonathan Spicer

Sandra Hodgetts

Chelsia Gillis

Sambasivarao Damaraju

Richard Thompson

Normand Boule

Nutritional strategies against skeletal muscle wasting in cancer-associated cachexia: the role of β-hydroxybutyrate and polyunsaturated fatty acids.